Ralph Tyler's Departure As FDA Chief Counsel Leaves Another Chair To Fill
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has not yet named an interim replacement; the agency has more than a dozen leadership positions being filled on an acting basis and five vacancies.
You may also be interested in...
Spielberg’s Replacement At FDA Also Will Have Strong Industry Ties
Former J&J and Sandoz executive Leona Brenner-Gati to become acting deputy commissioner for medical products and tobacco following the departure of Stephen Spielberg.
FDA's Elizabeth Dickinson Is Named Acting Chief Counsel
Dickinson, who has been a staff attorney since 1994, takes the helm from Ralph Tyler on an interim basis.
FDA's Elizabeth Dickinson Is Named Acting Chief Counsel
Dickinson, who has been a staff attorney since 1994, takes the helm from Ralph Tyler on an interim basis.